Bionovis

Brazilian pharmaceutical biotechnology company founded in 2012 and wholly dedicated to biopharmaceuticals, covering research, development, production and marketing of highly complex biological and biosimilar medicines. Its plant in Valinhos, São Paulo, has three active-ingredient lines, reactors of over 20,000 litres and capacity for 250 kilos of protein a year. It covers haematology, immunology, neurology, oncology and ophthalmology.